About Onur Kutlu, MD
Specialties & classifications: General Surgery · Surgery
Onur Kutlu is listed in general surgery in Miami, FL. Languages listed: English, Turkish.
Compare Onur Kutlu, MD with featured bariatric surgeons in FL
Related hospital / center: The Sosa Clinic
Paid placement. Not an endorsement by Onur Kutlu, MD.
Questions and Answers
Where does Onur Kutlu practice?
The listed practice is in MIAMI, FL. Confirm the appointment address with the practice. Source
Reported procedures
Source-reported information; confirm current details directly.
Education and Training
- Education and training
Ankara University School of Medicine
Source ↗ - Education and training
Gulhane Military Medical Academy | Mayo Clinic | Texas Tech University Health Sciences Center
Source ↗ - Education and training
Medical University of South Carolina | University of Miami Miller School of Medicine
Source ↗
Source-reported information; confirm current details directly.
Reported credentials
Source-reported information; confirm current details directly.
Reported affiliations
- the University of Miami Health System and is certified by the American Board of Surgery Source ↗
- UNIVERSITY OF MIAMI Source ↗
Source-reported information; confirm current details directly.
Selected publications
- Assessing Textbook Oncologic Outcomes in Distal Pancreatectomy for Pancreatic Adenocarcinoma: A National Cancer Database Study. · 2026 Source ↗
- ASO Visual Abstract: Missingness in NCDB: A Novel Surrogate for Hepatobiliary Cancers Outcomes. · 2025 Source ↗
- Missingness in the National Cancer Database: A Novel Surrogate for Hepatobiliary Cancer Outcomes. · 2026 Source ↗
- SAGES-AHPBA 2025 guideline for the surgical management of bile duct injury following cholecystectomy. · 2026 Source ↗
- Automated assessment of laparoscopic pattern cutting skills using computer vision and deep learning. · 2025 Source ↗
- Correction: Are More Young, Western Patients Also Developing Hepatocellular Carcinoma? · 2025 Source ↗
- Are More Young, Western Patients Also Developing Hepatocellular Carcinoma? · 2025 Source ↗
- Quantifying the impact of surgical teams on each stage of the operating room process. · 2024 Source ↗
- Analytical approaches in surgical oncological research. · 2024 Source ↗
- High Ligation of the Inferior Mesenteric Artery in Left-Sided Colon and Rectal Cancer Resection: Rates of Success and Outcomes. · 2024 Source ↗
- R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed. · 2023 Source ↗
- Comparison of upper gastrointestinal series and symptom questionnaires with intraoperative diagnosis of hiatal hernia during sleeve gastrectomy. · 2023 Source ↗
- Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress? · 2022 Source ↗
- Long-Term Outcomes after Adolescent Bariatric Surgery. · 2022 Source ↗
- Diaphragmatic Hernia With Incarcerated Spleen as a Complication After Lateral Anterior Column Realignment. · 2022 Source ↗
- High-Quality Surgery for Gallbladder Carcinoma: Rare, Associated with Disparity, and Not Substitutable by Chemotherapy. · 2022 Source ↗
- Is minimally invasive surgery for large gastric GIST actually safe? A comparative analysis of short- and long-term outcomes. · 2022 Source ↗
- Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. · 2022 Source ↗
- Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database. · 2022 Source ↗
- Margin Positivity and Survival in Papillary Thyroid Microcarcinoma: A National Cancer Database Analysis. · 2021 Source ↗
- The impact of chemotherapy sequencing on resectable pancreatic cancer by stage. · 2022 Source ↗
- Poorly differentiated hepatocellular carcinoma: resection is equivalent to transplantation in patients with low liver fibrosis. · 2022 Source ↗
- Strategic response to bleeding in laparoscopic hepato-pancreato-biliary surgery: an intraoperative checklist. · 2022 Source ↗
- Race, Age, Gender, and Insurance Status: A Comparative Analysis of Access to and Quality of Gastrointestinal Cancer Care. · 2021 Source ↗
- Corrigendum to High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas: [Journal of Surgical Research 256 (2020) 198-205]. · 2021 Source ↗
- ASO AUTHOR REFLECTIONS: Laparoscopic Distal Pancreatectomy for Pancreatic Cancer: Good, Bad, or Even Ugly? · 2021 Source ↗
- Does a Laparoscopic Approach to Distal Pancreatectomy for Cancer Contribute to Optimal Adjuvant Chemotherapy Utilization? · 2021 Source ↗
- COVID-19's Impact on Cancer Care: Increased Emotional Stress in Patients and High Risk of Provider Burnout. · 2022 Source ↗
- Clinical Prognosticators of Metastatic Potential in Patients with Small Pancreatic Neuroendocrine Tumors. · 2021 Source ↗
- Laparoscopic pancreatectomy for cancer in high volume centers is associated with an increased use and fewer delays of adjuvant chemotherapy. · 2021 Source ↗
- Margin Positivity and Survival Outcomes: A Review of 14,471 Patients with 1-cm to 4-cm Papillary Thyroid Carcinoma. · 2021 Source ↗
- Western population-based study of oncologic surgical quality and outcomes of laparoscopic versus open gastrectomy for gastric adenocarcinoma. · 2021 Source ↗
- High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas. · 2020 Source ↗
- Combining Appleby with RAMPS - Laparoscopic Radical Antegrade Modular Pancreatosplenectomy with Celiac Trunk Resection. · 2020 Source ↗
- Preoperative Chemotherapy for Pancreatic Cancer Improves Survival and R0 Rate Even in Early Stage I. · 2020 Source ↗
- Preoperative Prognosticators of Safe Laparoscopic Hepatocellular Carcinoma Resection in Advanced Cirrhosis: a Propensity Score Matching Population-Based Analysis of 1799 Western Patients. · 2019 Source ↗
- Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis. · 2018 Source ↗
- Minimally invasive management of the entire treatment sequence in patients with stage IV colorectal cancer: a propensity-score weighting analysis. · 2018 Source ↗
- Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma. · 2017 Source ↗
Source-reported information; confirm current details directly.
Professional identifier
NPI: 1881905941
Insurance reported
AetnaAvMed
Blue Cross and Blue Shield of Florida
Blue Cross Blue Shield
Blue Cross Blue Shield of Florida
Blue Cross Blue Shield of Georgia
CignaFirst Health
Florida Blue
HumanaInc. d/b/a Florida Blue
UnitedHealthcare
Reported in source records. Confirm the exact plan, network and procedure with the practice and insurer. Logos identify brands; they do not establish participation.
Ratings & reviews
Write a review